Hubert L. Allen, Executive Vice President at ABBOTT LABORATORIES (ABT), sold 146 shares at $35.75 ($5K) on 2013-07-22, disclosed to the SEC on 2013-07-24.
Scheduled sale ($5k) by Executive Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ABT | SELL | 2024-03-04 | $202K | — | Filing → |
| ABT | SELL | 2023-03-02 | $215K | — | Filing → |
| ABT | SELL | 2022-03-02 | $343K | — | Filing → |